Technology
Health
Biotechnology

Homology Medicines

$20.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.43 (-2.10%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell FIXX and other stocks, options, ETFs, and crypto commission-free!

About

Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Read More The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.

Employees
124
Headquarters
Bedford, Massachusetts
Founded
2015
Market Cap
750.62M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
172.00K
High Today
$20.91
Low Today
$20.00
Open Price
$20.56
Volume
71.60K
52 Week High
$31.80
52 Week Low
$15.07

Collections

Technology
Health
Biotechnology
Therapy
2018 IPO
US
North America

News

Yahoo FinanceMay 13

Homology Medicines Reports Q1 Loss, Lags Revenue Estimates

Homology Medicines (FIXX) delivered earnings and revenue surprises of -16.36% and -73.00%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

17
Yahoo FinanceMay 9

Is Homology Medicines, Inc. A Good Stock To Buy?

At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices.

36
Yahoo FinanceMay 9

Homology Medicines to Present at Bank of America Merrill Lynch Health Care Conference

BEDFORD, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (FIXX), a genetic medicines company, announced today that Company management will participate during a fireside chat at the 2019 Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, at 4:20 p.m. PT at the Encore Hotel in Las Vegas. In addition, Arthur Tzianabos, Ph.D., President and Chief Executive Officer of Homology Medicines, will participate in the Gene Therapy Panel being held at the conference on Wednesday...

8

Earnings

-$0.64
-$0.58
-$0.51
-$0.45
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
-$0.64 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.